For scintigraphic imaging of cancers, including PET scans, and management of thyroid pathologies, including cancers.
Outpatient consultations
Secretariat
- Opening hours: Appointments are available Monday to Friday, 8:30 a.m. to 5 p.m.
- Telephone: 02 31 45 50 32
- Location: Centre ground floor
Hospitalization
Sheltered hospitalization
- Open: 24-hour service
- No visit
- Hospital secretariat: Monday to Friday, 8.30am to 4.30pm: 02 31 45 50 50 ext. 53.73
- Nursing office: 02 31 45 50 50 ext. 53.73
- Location: 7th floor
Department tasks
Care mission
The Nuclear Medicine department is involved in the diagnosis and treatment of thyroid cancers (iodine 131 and systemic treatments) and neuroendocrine tumors (Lutathera). It treats patients with thyroid cancer and refractory thyroid cancer.
Its main mission is to carry out :
- scintigraphic imaging (PET including various tracers and scintigraphs),
- treatment with metabolic radiotherapy (iodine 131, Lutathera),
- thyroid pathology consultations (thyroid nodules, thyroid cancer, hyperthyroidism, hypothyroidism...),
- thyroid ultrasound (with cytopunctions).
Research mission
The department participates in research activities in nuclear medicine and thyroid pathology.
Teaching mission
Every year, the department's doctors take part in various initial and continuing training programs: DPC teaching for general practitioners, medical interns and externs, pharmacy interns and externs, and medical electroradiology technician trainees. The department is also a training ground for interns, externs and trainee manipulators.
The team
- Department Head: Dr Stéphane BARDET
- Health executive: Antoine MARIE
- Nuclear physicians: Dr Stéphane BARDET, Dr Renaud CIAPPUCINI, Dr Elisabeth QUAK
- Thyroid consultations: Dr Stéphane BARDET, Dr Paul-Antoine BOMPAIN, Dr Renaud CIAPPUCINI, Dr Véronique LE HENAFF, Dr Barbara LIREUX
- Radiation protection: Alain BATALLA
- Medical physicist: Cyril JAUDET
- Radiopharmacists: Dr Gauthier FOUCRAS, Dr Anaïs PRIGENT
Care services
For diagnostic purposes
Nuclear medicine enables us to explore the functioning of numerous organs and detect diseased tissue, in a targeted population ranging from infants to the elderly. Scintigraphy procedures vary from one type of examination to another, and are adapted to the clinical situation of each patient. In general, examinations are carried out in two stages: the first involves injection of the radioactive drug, followed a few minutes to a few hours later by the 2nd stage, when the images are taken.
The Centre's nuclear medicine department is particularly dedicated to oncology and endocrine investigations, including :
- PET with FDG or other tracers (choline, FNa, DOPA)
- Gallium-68 DOTA-Toc PET scan
- Bone scintigraphy
- Thyroid scintigraphy
- Parathyroid scintigraphy
- Isotopic calculation of cardiac ejection fraction
- Sentinel node detection for cancers of the breast, skin, head and neck, gynecological and urological systems
- Octreoscan
The department has set up a Thyroid Rapid Diagnosis Day.
Therapeutic use
Nuclear medicine is involved in the management of a number of diseases. The department is involved in the treatment of :
- Benign and malignant thyroid diseases (I131)
- Neuroendocrine tumors of the small intestine (LUTATHERA)
- Neuroblastoma (MIBG-I131)
Expertise
- Expertise in scintigraphic imaging including PET
- Expertise in thyroid pathologies, including cancers(TUTHYREF network expert center). Local and regional thyroid RCP.
- Expertise in metabolic radiotherapy thanks to the presence of radio-protected chambers (iodine 131 and LUTATHERA)
Equipment
- 3 gamma cameras :
- 1 BRIVO GE (2016)
- 1 Siemens Symbia T2 (2010) coupled with an X-ray register scanner
- 1 INTEVO bold Siemens (2020) coupled to an X-ray location scanner
- 1 Biograph Vision Siemens PET scanner (2020) located at Caen University Hospital.
Equipment shared with the Caen CHU team. - 1 Vereos Philips PET scanner (2017) located at the François Baclesse center.
Equipment shared with Caen University Hospital's nuclear physicians and the region's private nuclear physicians. - 4 radiation-protected rooms
Results
- Accreditation: EARL FDG PET/CT Centre of excellence
- Expert center for the national TUTHYREF network (THYroid REFractory Tumors)
- 5221 scintigraphy procedures
- 3,666 TEP Vereos (all shifts)
- 1,684 Siemens PETs (Baclesse activity)
- 2,311 thyroid consultations
- 241 rapid thyroid consultations
- 246 metabolic radiotherapy treatments
Research / Project
- Thyroid nodules
- PET : Instrumentation
- Parathyroid and FCH PET
Partnerships
- At the national level: TUTHYREF, working groups of the French Society of Nuclear Medicine
Publications
- Stéphane Bardet et al. Shear Wave Elastography in Thyroid Nodules with Indeterminate Cytology: Results of a Prospective Bicentric Study. Thyroid 2017
- Renaud Ciappuccini 18 F-Fluorocholine Positron Emission Tomography/Computed Tomography Is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study. Thyroid 2020
- Elske Quak et al. F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study . Eur J Nucl Med Mol Imaging 2017
Training courses
Initial training
- Training medical electroradiology technicians
- Training medical interns and externs as part of their hospital internships
Continuing education
- CPD for general practitioners on thyroid pathologies